Skip to main content
David Graham, MD, Oncology, Charlotte, NC, Atrium Health's Carolinas Medical Center

DavidLGrahamMD

Oncology Charlotte, NC

Genitourinary Oncology, Hematologic Oncology, Thoracic Cancer

Physician and Administrator at Levine Cancer Institute

Dr. Graham is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Graham's full profile

Already have an account?

Education & Training

  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1990 - 1993
  • Mayo Clinic College of Medicine and Science (Rochester)
    Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1987 - 1990
  • Mayo Clinic College of Medicine
    Mayo Clinic College of MedicineClass of 1987

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 2013 - 2024
  • IL State Medical License
    IL State Medical License 1993 - 2017
  • MN State Medical License
    MN State Medical License 1988 - 1994
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Abstracts/Posters

  • Second Cancers in Adults with Acute Promyelocytic Leukemia (APL) Treated with or without Arsenic Trioxide (ATO): A SEER-Medicare Analysis
    David J. Graham, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019

Press Mentions

  • ASCO 2019: The Eight Biggest Stories on Anticancer Agents
    ASCO 2019: The Eight Biggest Stories on Anticancer AgentsAugust 6th, 2019
  • More Clarity to Steroids' Effect on Anti-PD-1 Therapy
    More Clarity to Steroids' Effect on Anti-PD-1 TherapyJune 27th, 2019
  • Largest Race-Based Survival Advantage to Date Seen in Men Receiving Sipuleucel-T for mCRPC
    Largest Race-Based Survival Advantage to Date Seen in Men Receiving Sipuleucel-T for mCRPCJune 12th, 2019
  • Join now to see all

Professional Memberships

Hospital Affiliations